BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24313769)

  • 41. The lung microbiome in end-stage Lymphangioleiomyomatosis.
    Ng J; Pacheco-Rodriguez G; Begley L; Huang YJ; Poli S; Perrella MA; Rosas IO; Moss J; El-Chemaly S
    Respir Res; 2021 Oct; 22(1):277. PubMed ID: 34702264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations.
    Huang YJ; Kim E; Cox MJ; Brodie EL; Brown R; Wiener-Kronish JP; Lynch SV
    OMICS; 2010 Feb; 14(1):9-59. PubMed ID: 20141328
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics.
    Pragman AA; Knutson KA; Gould TJ; Hodgson SW; Isaacson RE; Reilly CS; Wendt CH
    PLoS One; 2019; 14(7):e0219962. PubMed ID: 31335912
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease.
    Cabrera-Rubio R; Garcia-Núñez M; Setó L; Antó JM; Moya A; Monsó E; Mira A
    J Clin Microbiol; 2012 Nov; 50(11):3562-8. PubMed ID: 22915614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bacterial-viral load and the immune response in stable and exacerbated COPD: significance and therapeutic prospects.
    D'Anna SE; Balbi B; Cappello F; Carone M; Di Stefano A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():445-53. PubMed ID: 27042037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The loss of topography in the microbial communities of the upper respiratory tract in the elderly.
    Whelan FJ; Verschoor CP; Stearns JC; Rossi L; Luinstra K; Loeb M; Smieja M; Johnstone J; Surette MG; Bowdish DM
    Ann Am Thorac Soc; 2014 May; 11(4):513-21. PubMed ID: 24601676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Host Response to the Lung Microbiome in Chronic Obstructive Pulmonary Disease.
    Sze MA; Dimitriu PA; Suzuki M; McDonough JE; Campbell JD; Brothers JF; Erb-Downward JR; Huffnagle GB; Hayashi S; Elliott WM; Cooper J; Sin DD; Lenburg ME; Spira A; Mohn WW; Hogg JC
    Am J Respir Crit Care Med; 2015 Aug; 192(4):438-45. PubMed ID: 25945594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lung microbiome dynamics in COPD exacerbations.
    Wang Z; Bafadhel M; Haldar K; Spivak A; Mayhew D; Miller BE; Tal-Singer R; Johnston SL; Ramsheh MY; Barer MR; Brightling CE; Brown JR
    Eur Respir J; 2016 Apr; 47(4):1082-92. PubMed ID: 26917613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Saliva Microbiome Changes in Patients With Periodontitis With and Without Chronic Obstructive Pulmonary Disease.
    Lin M; Li X; Wang J; Cheng C; Zhang T; Han X; Song Y; Wang Z; Wang S
    Front Cell Infect Microbiol; 2020; 10():124. PubMed ID: 32351901
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparative analysis of the alveolar microbiome in COPD, ECOPD, Sarcoidosis, and ILD patients to identify respiratory illnesses specific microbial signatures.
    Gupta S; Shariff M; Chaturvedi G; Sharma A; Goel N; Yadav M; Mortensen MS; Sørensen SJ; Mukerji M; Chauhan NS
    Sci Rep; 2021 Feb; 11(1):3963. PubMed ID: 33597669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients.
    Millares L; Pascual S; Montón C; García-Núñez M; Lalmolda C; Faner R; Casadevall C; Setó L; Capilla S; Moreno A; Castro-Acosta AA; Alvarez-Martinez CJ; Sibila O; Peces-Barba G; Cosio BG; Agustí A; Gea J; Monsó E
    BMC Pulm Med; 2019 Jun; 19(1):112. PubMed ID: 31234826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
    Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
    Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exome and Sputum Microbiota as Predictive Markers of Frequent Exacerbations in Chronic Obstructive Pulmonary Disease.
    Su L; Qiao Y; Luo J; Huang R; Xiao Y
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seasonal Dynamics of the Upper Respiratory Tract Microbiome in Chronic Obstructive Pulmonary Disease.
    Cai S; Gao J; Liu X; Yang J; Feng D; Li G; Li S; Yang H; Wang Z; Yi X; Zhou Y
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1267-1276. PubMed ID: 37362620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between gut microbiota and lung function decline in patients with chronic obstructive pulmonary disease: a 1-year follow-up study.
    Chiu YC; Lee SW; Liu CW; Lan TY; Wu LS
    Respir Res; 2022 Jan; 23(1):10. PubMed ID: 35033061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative analysis of pathogens in the lower respiratory tract of patients with chronic obstructive pulmonary disease.
    Wang H; Gu X; Weng Y; Xu T; Fu Z; Peng W; Yu W
    BMC Pulm Med; 2015 Aug; 15():94. PubMed ID: 26286268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls.
    Schubert AM; Rogers MA; Ring C; Mogle J; Petrosino JP; Young VB; Aronoff DM; Schloss PD
    mBio; 2014 May; 5(3):e01021-14. PubMed ID: 24803517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Specific IgA against
    Millares L; Martí S; Ardanuy C; Liñares J; Santos S; Dorca J; García-Nuñez M; Quero S; Monsó E
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2807-2811. PubMed ID: 29033561
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease.
    Pragman AA; Lyu T; Baller JA; Gould TJ; Kelly RF; Reilly CS; Isaacson RE; Wendt CH
    Microbiome; 2018 Jan; 6(1):7. PubMed ID: 29316977
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The sputum microbiome associated with different sub-types of AECOPD in a Chinese cohort.
    Wang J; Chai J; Sun L; Zhao J; Chang C
    BMC Infect Dis; 2020 Aug; 20(1):610. PubMed ID: 32811432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.